Recall of Sapphire Infusion Pump

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Hospira Pty Limited.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
    Class II
  • Event Initiated Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Extra notes in the data
  • Reason
    Q core (the sapphire infusion pump original manufacturer) has received complaints from customers that when using the epidural mode with patient bolus, the amount of medication delivered may be greater than programmed. in the sapphire pump, as in all infusion systems, external factors may cause fluctuations in flow rate accuracy. investigation of these complaints determined that the deviation observed is exclusively related to the use of catheters with a gauge smaller than that used for the sapphire pump flow accuracy calibration. no patient injuries or deaths have been reported as a result of this issue.
  • Action
    To address this issue, Q Core Medical is providing an addendum to the User Manual to assist customers in (i) identifying whether the catheter utilized may cause over-delivery, (ii) better understanding the effect of back pressure and catheter size on the accuracy of the delivered volume, (iii) translating the catheter’s back pressure to the degree of flow deviation that can be expected, and (iv) contacting Hospira Representative to determine if and to what extent specific catheter/pump combinations are susceptible to over-delivery. Future versions of the User Manual will incorporate the information contained in the addendum. This action has been closed-out on 30/08/2016.


  • Model / Serial
    Sapphire Infusion PumpHospira List Number: 163113601/163123601Q Core Number (on pump): 15031-000-0001 /15032-000-0001ARTG Number: 201499
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Source